Back to search

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

Data up to Jan 2025

Published1999
Citations169
References31

Total Citations Per Year

Abstract

References (31)

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

The Brief Psychiatric Rating Scale

1962 • 10,683 citations

The Global Deterioration Scale for assessment of primary degenerative dementia

1982 • 4,700 citations

Evaluating storage, retention, and retrieval in disordered memory and learning

1974 • 1,592 citations

Nicotinic acetylcholine binding sites in Alzheimer's disease

1986 • 485 citations

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in alzheimer's disease

1992 • 478 citations

Human neuronal nicotinic receptors

1997 • 418 citations

Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases

1992 • 324 citations

Intravenous nicotine in Alzheimer's disease: a pilot study

1988 • 312 citations

Characterization of <scp>l</scp>‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal

1986 • 288 citations

Nicotinic System Involvement in Alzheimer??s and Parkinson??s Diseases

1997 • 265 citations

Smoking, nicotine and human performance

1983 • 245 citations

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

1995 • 198 citations

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

1994 • 178 citations

Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?

1990 • 168 citations

Pharmacodynamic model of tolerance: application to nicotine.

1988 • 161 citations

Acute nicotinic blockade produces cognitive impairment in normal humans

1992 • 155 citations

Cognitive psychology and human memory

1988 • 149 citations

Nicotine enhances delayed matching-to-sample performance by primates

1988 • 144 citations

Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task

1990 • 137 citations

Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior

1994 • 135 citations

Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations

1988 • 134 citations

Human nicotinic receptors—Their role in aging and dementia

1994 • 117 citations

Cholinergic receptors in human brain: Effects of aging and alzheimer disease

1990 • 100 citations

Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with alzheimer's disease

1990 • 93 citations

Cholinergic Control of Cognitive Resources

1993 • 88 citations

Improvement of performance on an attention task with chronic nicotine treatment in rats

1972 • 40 citations

EFFECTS OF ATROPINE ON THE REPEATED ACQUISITION AND PERFORMANCE OF RESPONSE SEQUENCES IN HUMANS

1989 • 36 citations

Cholinergic Drug Studies in Dementia and Depression

1990 • 28 citations

Parametric statistical analysis of repeated measures experiments

1982 • 26 citations

Cited By (0)

No citing papers found in database

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418… (1999) – Psychopharmacology | Metascience Observatory Explorer